Inventor · disambiguated record
Ralph Adams
Also filed as: ADAMS RALPH · ADAMS RALPH C
41 granted patents·24 pending applications·299 citations·filing 1974–2025
98Inventor score
Top patents by PatentIndex Score
65 records- 0195US8784823B2Binding proteins, including antibodies, antibody derivatives and antibody fragments, that specifically bind CD154 and uses thereofUCB PHARMA SA·Filed 2012·Granted Jul 22, 2014·38 cites·7 claims
- 0295US8293237B2Binding proteins, including antibodies, antibody derivatives and antibody fragments, that specifically bind CD154 and uses thereofBURKLY LINDA C·Filed 2008·Granted Oct 23, 2012·40 cites·19 claims
- 0394US9873735B2Method of treatment with antibodies having specificity for human OX40UCB BIOPHARMA SPRL·Filed 2015·Granted Jan 23, 2018·12 cites·50 claims
- 0494US9040048B2Antibody molecules having specificity for human OX40UCB PHARMA SA·Filed 2012·Granted May 26, 2015·19 cites·11 claims
- 0593US8303953B2Antibody molecules which bind IL-17A and IL-17FADAMS RALPH·Filed 2007·Granted Nov 6, 2012·18 cites·12 claims
- 0692US8057794B2Antibody molecules which bind to human IL-17RAPECKI STEPHEN EDWARD·Filed 2007·Granted Nov 15, 2011·26 cites·12 claims
- 0791US8580265B2Antibody molecules which bind IL-17A and IL-17FADAMS RALPH·Filed 2012·Granted Nov 12, 2013·16 cites·10 claims
- 0891US8231875B2Neutralising antibody molecules having specificity for human IL-17ADAMS RALPH·Filed 2005·Granted Jul 31, 2012·15 cites·9 claims
- 0988US11261242B2Anti-alpha-synuclein antibodiesUCB Biopharma SRL·Filed 2018·Granted Mar 1, 2022·3 cites·21 claims
- 1088US11014979B2Anti-AP2 antibodies and antigen binding agents to treat metabolic disordersHARVARD COLLEGE·Filed 2018·Granted May 25, 2021·4 cites·35 claims
- 1188US9803004B2Albumin binding antibodies and binding fragments thereofUCB BIOPHARMA SPRL·Filed 2012·Granted Oct 31, 2017·10 cites·11 claims
- 1288US2024376191A1Antibody molecules which bind il-17a and il-17fUCB Biopharma SRL·Filed 2024·Application pending·0 cites
- 1386US8329431B2Nucleic acid molecules encoding neutralising antibodies having specificity for human IL-17ADAMS RALPH·Filed 2011·Granted Dec 11, 2012·6 cites·17 claims
- 1485US12247068B2Anti-AP2 antibodies and antigen binding agents to treat metabolic disordersHARVARD COLLEGE·Filed 2021·Granted Mar 11, 2025·1 cites·19 claims
- 1583US8486662B2DNA encoding antibody molecules having specificity for human IL-6GELINAS RICHARD EVAN·Filed 2011·Granted Jul 16, 2013·6 cites·15 claims
- 1683US8075889B2Antibody molecules having specificity for human IL-6GELINAS RICHARD EVAN·Filed 2006·Granted Dec 13, 2011·6 cites·7 claims
- 1782US10421816B2Multivalent antibodiesUCB PHARMA SA·Filed 2016·Granted Sep 24, 2019·2 cites·9 claims
- 1882US10160798B2Anti-aP2 antibodies and antigen binding agents to treat metabolic disordersHARVARD COLLEGE·Filed 2016·Granted Dec 25, 2018·4 cites·48 claims
- 1982US10023631B2Albumin binding antibodies and binding fragments thereofUCB BIOPHARMA SPRL·Filed 2017·Granted Jul 17, 2018·3 cites·3 claims
- 2082US9988446B2Methods of treatment using antibodies which bind IL-17A and IL-17FUCB BIOPHARMA SPRL·Filed 2015·Granted Jun 5, 2018·2 cites·26 claims
- 2180US3933631AMethod of operating ion exchange systemPERMUTIT CO·Filed 1974·Granted Jan 20, 1976·38 cites·3 claims
- 2280US2023135399A1Binding proteins, including antibodies, antibody derivatives and antibody fragments, that specifically bind cd154 and uses thereofUCB Biopharma SRL·Filed 2022·Application pending·0 cites
- 2379US9321840B2Binding proteins, including antibodies, antibody derivatives and antibody fragments, that specifically bind CD154 and uses thereofUCB PHARMA SA·Filed 2014·Granted Apr 26, 2016·2 cites·15 claims
- 2479US8435761B2DNA encoding antibody molecules which bind human IL-17RAPECKI STEPHEN EDWARD·Filed 2011·Granted May 7, 2013·4 cites·6 claims
- 2578US11919950B2Expression vector encoding antibody molecule which binds IL-17A and IL-17FUCB Biopharma SRL·Filed 2020·Granted Mar 5, 2024·0 cites·8 claims
- 2678US10308723B2Method of treating inflammation by administering antibody molecules which bind IL-17A and IL-17FUCB BIOPHARMA SPRL·Filed 2017·Granted Jun 4, 2019·1 cites·9 claims
- 2778US8865167B2Neutralising antibody molecules having specificity for human IL-17UCB PHARMA SA·Filed 2012·Granted Oct 21, 2014·2 cites·7 claims
- 2877US10562966B2Antibodies of the class IGG4HUMPHREYS DAVID PAUL·Filed 2011·Granted Feb 18, 2020·4 cites·19 claims
- 2977US9096668B2Methods for making antibody molecules having specificity for human IL-6UCB PHARMA SA·Filed 2013·Granted Aug 4, 2015·2 cites·3 claims
- 3076US2025011473A1ANTI-IgE ANTIBODIESUCB Biopharma SRL·Filed 2024·Application pending·0 cites
- 3176US2024352083A1Antibodies comprising a polypeptide inserted in framework 3 regionUCB Biopharma SRL·Filed 2024·Application pending·0 cites
- 3275US9034600B2DNA encoding antibody molecules which bind IL-17A and IL-17FUCB PHARMA SA·Filed 2013·Granted May 19, 2015·1 cites·9 claims
- 3374US10407513B2Biological productsADAMS RALPH·Filed 2009·Granted Sep 10, 2019·3 cites·8 claims
- 3474US9890219B2Methods of treating an IL-17A mediated pathological conditionUCB BIOPHARMA SPRL·Filed 2015·Granted Feb 13, 2018·1 cites·14 claims
- 3574US9249232B2Framework selectionADAMS RALPH·Filed 2007·Granted Feb 2, 2016·1 cites·10 claims
- 3674US8617847B2Nucleic acids encoding antibody molecules which bind IL-17A and IL-17FUCB PHARMA SA·Filed 2012·Granted Dec 31, 2013·1 cites·17 claims
- 3773US9631015B2Methods for treating IL-6 mediated diseases with antibody molecules specific for IL-6UCB PHARMA SA·Filed 2015·Granted Apr 25, 2017·1 cites·7 claims
- 3873US2025346654A1Anti-ap2 antibodies and antigen binding agents to treat metabolic disordersHARVARD COLLEGE·Filed 2025·Application pending·0 cites
- 3971US12054559B2Anti-IgE antibodiesUCB Biopharma SRL·Filed 2021·Granted Aug 6, 2024·0 cites·12 claims
- 4069US12091450B2Antibodies of the class IGG4UCB PHARMA SA·Filed 2019·Granted Sep 17, 2024·0 cites·6 claims
- 4167US11999772B2Antibodies comprising a polypeptide inserted in framework 3 regionUCB Biopharma SRL·Filed 2019·Granted Jun 4, 2024·0 cites·32 claims
- 4266US2019233530A1Binding proteins, including antibodies, antibody derivatives and antibody fragments, that specifically bind cd154 and uses thereofUCB BIOPHARMA SPRL·Filed 2019·Application pending·0 cites
- 4365US2015147331A1Neutralising Antibody Molecules having Specificity for Human IL-17UCB PHARMA SA·Filed 2014·Application pending·0 cites
- 4465US2018346561A1Antibody molecules which bind il-17a and il-17fUCB BIOPHARMA SPRL·Filed 2018·Application pending·0 cites
- 4564US2014186355A1Nucleic Acids Encoding Antibody Molecules Which Bind IL-17A and IL-17FUCB PHARMA SA·Filed 2013·Application pending·0 cites
- 4663US2014044732A1Nucleic Acids Encoding Antibody Molecules Which Bind IL-17A and IL-17FUCB PHARMA SA·Filed 2013·Application pending·0 cites
- 4761US2025266122A1Multi-domain proteins with increased native state colloidal stabilityUCB Biopharma SRL·Filed 2025·Application pending·0 cites
- 4861US2017275355A1Neutralising antibody molecules having specificity for human il-17UCB BIOPHARMA SPRL·Filed 2017·Application pending·0 cites
- 4959US2023374148A1Binding molecules that multimerise cd45UCB Biopharma SRL·Filed 2021·Application pending·0 cites
- 5058US12327614B2Multi-domain proteins with increased native state colloidal stabilityUCB Biopharma SRL·Filed 2019·Granted Jun 10, 2025·0 cites·18 claims
Showing the top 50 of 65 patent records by PatentIndex Score.
Join the waitlist — get patent alerts
Get an alert when Ralph Adams files or is granted a new patent.
We store only your email — no account needed. See our privacy policy.
Identity basis: PatentsView inventor disambiguation (2025Q4-odp release). How scoring works →